- Home
- SBAC vs RPRX Comparison
SBAC vs RPRX Comparison
Compare SBAC & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBAC
- RPRX
- Stock Information
- Founded
- SBAC 1989
- RPRX 1996
- Country
- SBAC United States
- RPRX United States
- Employees
- SBAC N/A
- RPRX N/A
- Industry
- SBAC Real Estate Investment Trusts
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SBAC Real Estate
- RPRX Health Care
- Exchange
- SBAC Nasdaq
- RPRX Nasdaq
- Market Cap
- SBAC 20.2B
- RPRX 16.2B
- IPO Year
- SBAC 1999
- RPRX 2020
- Fundamental
- Price
- SBAC $196.00
- RPRX $37.82
- Analyst Decision
- SBAC Buy
- RPRX Strong Buy
- Analyst Count
- SBAC 15
- RPRX 3
- Target Price
- SBAC $240.53
- RPRX $46.00
- AVG Volume (30 Days)
- SBAC 1.1M
- RPRX 2.4M
- Earning Date
- SBAC 11-03-2025
- RPRX 11-05-2025
- Dividend Yield
- SBAC 2.26%
- RPRX 2.33%
- EPS Growth
- SBAC 25.44
- RPRX 54.86
- EPS
- SBAC 7.95
- RPRX 2.32
- Revenue
- SBAC $2,789,256,000.00
- RPRX $2,305,243,000.00
- Revenue This Year
- SBAC $6.84
- RPRX $36.16
- Revenue Next Year
- SBAC $2.41
- RPRX $2.04
- P/E Ratio
- SBAC $24.68
- RPRX $16.28
- Revenue Growth
- SBAC 4.82
- RPRX 3.02
- 52 Week Low
- SBAC $185.45
- RPRX $24.05
- 52 Week High
- SBAC $245.16
- RPRX $38.08
- Technical
- Relative Strength Index (RSI)
- SBAC 51.27
- RPRX 61.20
- Support Level
- SBAC $188.64
- RPRX $35.92
- Resistance Level
- SBAC $194.19
- RPRX $37.40
- Average True Range (ATR)
- SBAC 4.39
- RPRX 0.79
- MACD
- SBAC 0.36
- RPRX 0.08
- Stochastic Oscillator
- SBAC 67.92
- RPRX 88.24
About SBAC SBA Communications Corporation
SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.